The Candlelighters Supportive Care Research Centre

Did you know that of all children who die with cancer, 1 in 3 will die not because of the cancer, but because of the side effects of treatment? Worse still, research into reducing these side effects for children is under-resourced, sparse, and inadequate.

Amazing progress has been made in understanding and treating childhood cancers. Today, around 80% of children or young people diagnosed with cancer survive.

But despite advances in curative medicine, little has been done to improve the experience of living through and beyond cancer. Children often receive cancer treatments designed for adults and the impact on their smaller bodies can be severe. They suffer horrible side effects which can be traumatic, permanent, and even deadly.

Meet Ralph

Six-year-old Ralph has T-cell lymphoma.

The treatment he’s receiving is incredibly effective; it began immediately and he is responding well to it. But it’s shocking to see what the side effects are doing to his little body...

The chemotherapy is aggressive and makes him sick. It decays his teeth and five have to be removed. His skin is sore and painful to touch. His immune system is severely suppressed, and he develops sepsis. Ralph’s mum, Cleo says, “No one can prepare you for the side effects. He couldn’t walk, he swelled up from steroids, he would scream in agony.

If the side effects of Ralph’s treatment aren’t controlled properly, there’s even a risk he could die. We urgently need better ways to care for Ralph that will limit his side effects, reduce his suffering, and improve his quality of life and chance of survival.

The care Ralph needs doesn’t exist yet – but it will.

Introducing the Candlelighters Supportive Care Research Centre

Developing effective, kinder care is the best and fastest way to improve the lives of children with cancer and increase their chances of survival. The research that will help us do this is called supportive care.


What is Supportive Care?

Supportive care refers to everything except the treatment of the cancer itself. Supportive care includes preventing side effects of treatment, managing pain and reducing infection. It’s the care that gives children as full a life as possible.


We know research makes a difference. After all, because of research, the five-year survival rate for children’s cancers increased from 73% to 86% between 1997 and 2016. Now, we’re establishing the first Candlelighters Supportive Care Research Centre (CSCRC) at the University of York to develop effective, kinder care for young people with cancer, which will save lives, reduce suffering, and bring hope.

The CSCRC will enable the world’s leading supportive care experts to carry out high-quality research. It will invest in future supportive care specialists. And it will save lives, reduce suffering and bring hope to young people with cancer – not just in Yorkshire, but around the world.

As part of our commitment to childhood cancer research, we’ve worked closely with experts to identify the huge impact that can be made through improved supportive care. We believe our Research Centre can change the landscape of cancer care and transform what it means to undergo cancer treatment as a child.

Here, a team of experts will conduct high-value research which will rapidly advance the care of children and young people with cancer. Creating the Candlelighters Supportive Care Research Centre is a five-year project which will cost just under £1m. Together, we can make it a reality.

In the last 25 years alone we have invested over £11m into childhood cancer research, to improve early diagnosis, survival rates, treatments and quality of life, and develop experts for the future. Now, we want to take our commitment to the next level,

What impact will the Candlelighters Supportive Care Research Centre have?

In the short term, we will look at how to minimise hospital stays, prevent severe mucositis (mouth ulcers) and prevent nausea and vomiting. In the long-term (5-15 years), we aim to see:

  • A team of new, capable researchers who will take studies to the next level.
  • Fewer children and young people dying from side effects caused by cancer treatment.
  • Better nutritional interventions and improved psychological and social support.
  • Sustainable generation of grant income to continue to produce high-quality research.
  • A Yorkshire-based, world-class centre of excellence in research, impacting global care.

We want to ensure young people and their families are at the heart of our research. To learn more about how you can have your say on the research the centre will do, visit here.

We're currently looking for people, businesses or foundations who may be able to help with funding support for this ground-breaking research. If you would like to be involved or would like to find out more, email [email protected].

Our stories

Company of the Month… Mowgli!
29-10-20Our stories • Posted by Sean Donnelly
This month’s Company of the Month is Mowgli! Mowgli chose to start supporting Candlelighters in early 2020 at their newly opened Leeds restaurant on Boar Lane. Mowgli already has restaurants in Manchester, Liverpool and Sheffield among other cities, the Leeds restaurant was due to open in March however this had to be postponed due to …
Your very own spook-tacular Colour in Champ! 
13-10-20Our stories • Posted by Sean Donnelly
Boo! Fancy an afternoon of fun Halloween crafting? Why not get started with our very own spook-tacular Colour in Champ!  We would Lo-o-o-o-oVE to see your very scary creations… why not send in a photo to our inbox, [email protected] or tag us on social media? DOWNLOAD your colouring-in sheet here: Halloween Champ!  
Meet Hattie
18-09-20Our stories • Posted by Sean Donnelly
BE BRAVE, BE BOLD, BE GOLD!  ‘This is Hattie. She has just turned two and was diagnosed with a mediastinal (chest) germ cell tumour in May 2020. Symptoms began to show around 2-3 weeks before Hattie’s diagnosis. She had temperatures similar to that shown when teething or with a viral infection. When they continued for …
Meet Teagan
18-09-20Our stories • Posted by Sean Donnelly
BE BRAVE, BE BOLD, BE GOLD!  Today’s post comes with a special message from Teagan, inviting you all to join us TONIGHT for Champ’s BIG Golden Quiz! Starting at 6:30pm with your host Dr Bob Phillips!  ‘Taegan, aged 12, was diagnosed with an ovarian germ cell tumour on 6th December 2018. She spent time on …
Meet Harry
17-09-20Our stories • Posted by Sean Donnelly
BE BRAVE, BE BOLD, BE GOLD!  ‘Harry was diagnosed with Neuroblastoma cancer stage 4 in November 2011, aged four. He’d had intermittent pain in his legs, pain in his tummy and high temperatures a few weeks before diagnosis. After several trips to the doctors and A&E, he finally had an ultrasound scan which spotted his …
Meet Maisie
17-09-20Our stories • Posted by Sean Donnelly
BE BRAVE, BE BOLD, BE GOLD! ‘My daughter Maisie was diagnosed with ALL (acute lymphoblastic leukaemia) in September 2018 when she was just 19 months old. She is in maintenance now, hoping to complete treatment in November this year. She has been treated in Leeds LGI and supported by Airedale community nurses too. She has …
Company of the Month… Caddick Group!
15-09-20Our stories • Posted by Gaby Stead
This month’s Company of the Month is Caddick Group! In the last 18 months, the Caddick Group have donated over £21,000 to Candlelighters. This began with their decision to fund a day at Candlelighters in February 2019. This year, the Caddick Group hosted the incredible ‘Moment In Time’ Ball on February 29th, raising £12,000 for …
14-09-20Our stories • Posted by Sean Donnelly
BE BRAVE, BE BOLD, BE GOLD!  ‘Harry was diagnosed with Neuroblastoma cancer stage 4 in November 2011, aged four. He’d had intermittent pain in his legs, pain in his tummy and high temperatures a few weeks before diagnosis. After several trips to the doctors and A&E, he finally had an ultrasound scan which spotted his …
Meet Leighton
10-09-20Our stories • Posted by Sean Donnelly
BE BRAVE, BE BOLD, BE GOLD!  ‘Hi my name is Leighton and I am eight years old. I was diagnosed with a brain tumour on my brain stem in February 2019 called Medulloblastoma which was re-categorised after removal, to a large cell Anaplastic Medulloblastoma. Before I was diagnosed I had really bad headaches, was sick …
Meet Joseph
07-09-20Our stories • Posted by Sean Donnelly
BE BRAVE. BE BOLD. BE GOLD! ‘This is our family. Our son, Joseph, was diagnosed with high-risk Neuroblastoma when he was three. He finished treatment but later relapsed and died age seven, leaving an enormous hole in our hearts.  No matter what life threw at him, he always had a cheeky smile and infectious giggle. …

Your stories